11 research outputs found
The role of p53 in resistance mechanisms. Do we know how to use it in cancer practice in 2005?
No full textNeoadjuvant weekly paclitaxel, and epirubicin (PE) in patients with inflammatory and T4 breast cancer (IBC-T4BC): Result of a VAR Cancer Society tria
No full textNeoadjuvant weekly paclitaxel, and epirubicin (PE) in patients with inflammatory and T4 breast cancer (IBC-T4BC): Result of a VAR Cancer Society tria
No full text
Retrospective analysis of 561 breast magnetic resonance imaging (MRI). The largest study to dat
No full textRetrospective analysis of 561 breast magnetic resonance imaging (MRI). The largest study to dat
No full text
